Drug intelligence / Profile preview

DermaNail

Development stage: Unknown
Lead developer: Summers Laboratories
Modality: Small Molecules
Administration: Topical

Overview

DermaNail is an over-the-counter topical nail conditioner developed and marketed by Summers Laboratories for the treatment of brittle nails and related cosmetic nail conditions such as chipping, peeling, and splitting. The product's active ingredient is acetyl mandelic acid, which works by binding corneocyte cells within the nail plate to increase hardness and structural integrity. Formulated as a topical solution containing isopropyl alcohol and butylene glycol, it is designed to penetrate the nail plate rather than acting as a surface lacquer. It is typically applied twice daily and is often recommended for use in conjunction with Cutemol Emollient Cream for comprehensive nail and cuticle care.

Brand names: DermaNail

Beyond the preview

Go deeper on DermaNail.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DermaNail.

Explore the full profile